3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Nasopharyngeal Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
2
Cisplatin
2
Carboplatin
2
tocilizumab
1
infigratinib
1
etoposide phosphate
1
avelumab
1
apatinib
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Radiotherapy
1
Paclitaxel
1
Nelfinavir
1
Induction Chemotherapy
1
Immunohistochemistry
1
Ifosfamide
1
Fluorouracil
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
Etoposide
1
Electroacupuncture
1
Dexamethasone
1
Biopsy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Nasopharyngeal Neoplasms
×
Induction Chemotherapy
×
Clear all
NCT00828386
2019-01-18
NPC2006
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3
Terminated
83 enrolled